Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_anomalous, AVS_full
BMRB Entry DOI: doi:10.13018/BMR17415
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Asciutto, Eliana; Dang, Marina; Pochapsky, Susan Sondej; Madura, Jeffry; Pochapsky, Thomas. "Experimentally Restrained Molecular Dynamics Simulations for Characterizing the Open States of Cytochrome P450(cam)." Biochemistry 50, 1664-1671 (2011).
PubMed: 21265500
Assembly members:
entity_1, polymer, 413 residues, 45643.371 Da.
HEM, non-polymer, 616.487 Da.
CAM, non-polymer, 152.233 Da.
Natural source: Common Name: Pseudomonas putida Taxonomy ID: 303 Superkingdom: Bacteria Kingdom: not available Genus/species: Pseudomonas putida
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: N/A
Data type | Count |
13C chemical shifts | 596 |
15N chemical shifts | 295 |
1H chemical shifts | 298 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | cytochrome P450cam | 1 |
2 | CAM | 3 |
3 | PROTOPORPHYRIN IX CONTAINING FE | 2 |
Entity 1, cytochrome P450cam 413 residues - 45643.371 Da.
1 | THR | GLU | THR | ILE | GLN | SER | ASN | ALA | ASN | LEU | ||||
2 | ALA | PRO | LEU | PRO | PRO | HIS | VAL | PRO | GLU | HIS | ||||
3 | LEU | VAL | PHE | ASP | PHE | ASP | MET | TYR | ASN | PRO | ||||
4 | SER | ASN | LEU | SER | ALA | GLY | VAL | GLN | GLU | ALA | ||||
5 | TRP | ALA | VAL | LEU | GLN | GLU | SER | ASN | VAL | PRO | ||||
6 | ASP | LEU | VAL | TRP | THR | ARG | CYS | ASN | GLY | GLY | ||||
7 | HIS | TRP | ILE | ALA | THR | ARG | GLY | GLN | LEU | ILE | ||||
8 | ARG | GLU | ALA | TYR | GLU | ASP | TYR | ARG | HIS | PHE | ||||
9 | SER | SER | GLU | CYS | PRO | PHE | ILE | PRO | ARG | GLU | ||||
10 | ALA | GLY | GLU | ALA | TYR | ASP | PHE | ILE | PRO | THR | ||||
11 | SER | MET | ASP | PRO | PRO | GLU | GLN | ARG | GLN | PHE | ||||
12 | ARG | ALA | LEU | ALA | ASN | GLN | VAL | VAL | GLY | MET | ||||
13 | PRO | VAL | VAL | ASP | LYS | LEU | GLU | ASN | ARG | ILE | ||||
14 | GLN | GLU | LEU | ALA | CYS | SER | LEU | ILE | GLU | SER | ||||
15 | LEU | ARG | PRO | GLN | GLY | GLN | CYS | ASN | PHE | THR | ||||
16 | GLU | ASP | TYR | ALA | GLU | PRO | PHE | PRO | ILE | ARG | ||||
17 | ILE | PHE | MET | LEU | LEU | ALA | GLY | LEU | PRO | GLU | ||||
18 | GLU | ASP | ILE | PRO | HIS | LEU | LYS | TYR | LEU | THR | ||||
19 | ASP | GLN | MET | THR | ARG | PRO | ASP | GLY | SER | MET | ||||
20 | THR | PHE | ALA | GLU | ALA | LYS | GLU | ALA | LEU | TYR | ||||
21 | ASP | TYR | LEU | ILE | PRO | ILE | ILE | GLU | GLN | ARG | ||||
22 | ARG | GLN | LYS | PRO | GLY | THR | ASP | ALA | ILE | SER | ||||
23 | ILE | VAL | ALA | ASN | GLY | GLN | VAL | ASN | GLY | ARG | ||||
24 | PRO | ILE | THR | SER | ASP | GLU | ALA | LYS | ARG | MET | ||||
25 | CYS | GLY | LEU | LEU | LEU | VAL | GLY | GLY | LEU | ASP | ||||
26 | THR | VAL | VAL | ASN | PHE | LEU | SER | PHE | SER | MET | ||||
27 | GLU | PHE | LEU | ALA | LYS | SER | PRO | GLU | HIS | ARG | ||||
28 | GLN | GLU | LEU | ILE | GLU | ARG | PRO | GLU | ARG | ILE | ||||
29 | PRO | ALA | ALA | CYS | GLU | GLU | LEU | LEU | ARG | ARG | ||||
30 | PHE | SER | LEU | VAL | ALA | ASP | GLY | ARG | ILE | LEU | ||||
31 | THR | SER | ASP | TYR | GLU | PHE | HIS | GLY | VAL | GLN | ||||
32 | LEU | LYS | LYS | GLY | ASP | GLN | ILE | LEU | LEU | PRO | ||||
33 | GLN | MET | LEU | SER | GLY | LEU | ASP | GLU | ARG | GLU | ||||
34 | ASN | ALA | CYS | PRO | MET | HIS | VAL | ASP | PHE | SER | ||||
35 | ARG | GLN | LYS | VAL | SER | HIS | THR | THR | PHE | GLY | ||||
36 | HIS | GLY | SER | HIS | LEU | CYS | LEU | GLY | GLN | HIS | ||||
37 | LEU | ALA | ARG | ARG | GLU | ILE | ILE | VAL | THR | LEU | ||||
38 | LYS | GLU | TRP | LEU | THR | ARG | ILE | PRO | ASP | PHE | ||||
39 | SER | ILE | ALA | PRO | GLY | ALA | GLN | ILE | GLN | HIS | ||||
40 | LYS | SER | GLY | ILE | VAL | SER | GLY | VAL | GLN | ALA | ||||
41 | LEU | PRO | LEU | VAL | TRP | ASP | PRO | ALA | THR | THR | ||||
42 | LYS | ALA | VAL |
Entity 3, CAM - C10 H16 O - 152.233 Da.
1 | CAM |
Entity 2, PROTOPORPHYRIN IX CONTAINING FE - C34 H32 Fe N4 O4 - 616.487 Da.
1 | HEM |
sample_1: cytochrome P450cam, [U-100% 13C; U-100% 15N; U-80% 2H], 0.4 ± .03 mM; H2O 90%; D2O 10%; CYP101A1 0.4 mM; CAM 3 mM; KCl 100 mM
sample_2: cytochrome P450cam, [U-15N], 0.4 ± 0.02 mM; H2O 90%; D2O 10%; CYP101A1 0.4 mM; CAM 3 mM; KCl 100 mM; C12E5/hexanol 5%
sample_3: cytochrome P450cam, [U-15N], 0.4 ± 0.02 mM; H2O 90%; D2O 10%; CYP101A1 0.4 mM; CAM 3 mM; KCl 100 mM; pf1 8 mg/mL
sample_conditions_1: ionic strength: 100 mM; pH: 7.4; pressure: 1 atm; temperature: 298 K
sample_conditions_2: ionic strength: 100 mM; pH: 7.4; pressure: 1 atm; temperature: 298 K
sample_conditions_3: ionic strength: 100 mM; pH: 7.4; pressure: 1 atm; temperature: 298 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HNCACB | sample_1 | isotropic | sample_conditions_1 |
3D 1H-15N NOESY | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N TROSY-semiTROSY | sample_2 | anisotropic | sample_conditions_2 |
2D 1H-15N TROSY-semiTROSY | sample_3 | anisotropic | sample_conditions_3 |
AMBER v10, Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollm - refinement
BMRB | 16753 19038 19740 19763 |
PDB | |
DBJ | BAN13286 |
GB | AAA25760 |
REF | WP_032492633 YP_009083112 |
SP | P00183 |
AlphaFold | P00183 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks